Oncofid-P-B (paclitaxel-hyaluronic acid) in the intravesical therapy of patients affected by primary or recurrent Ta G1-G2 papillary cancer of the bladder. A phase II marker lesion study
Bassi, P.F., Racioppi, M., Palermo, G., Selli, C., Battaglia, M., Gontero, P., Simeone, C., Eisendhardt, A., Vom Dorp, F., Neisius, A., Arjona, M.F., Castro Diaz, D., Ramirez Backhaus, M., Moreno SierVolume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)31567-7
Date:
March, 2018
File:
PDF, 85 KB
english, 2018